Skip to main content
TipRanks
Go Ultimate75% OFF

1st Group Ltd. (VFX) AI Stock Analysis

3 Followers
AU:VFX

1st Group Ltd.

(ASX:VFX)

Select Model
Rating:37Underperform
Price Target:AUD 0.04▼(-5.13% Downside)
Action:downgraded
Date:10/01/26

The stock scores at the absolute minimum of 37, reflecting a convergence of extreme risks. The most significant factor is the company's critical financial state, marked by insolvency, deep operating losses, and unsustainable cash burn. This is compounded by a persistently bearish technical trend and a valuation that signals no underlying earnings power. The company's survival is in question, making it an extremely high-risk investment.

Positive Factors
Sharp Net-Loss ImprovementThe dramatic reduction in net loss indicates that cost actions or other earnings improvements are having a meaningful effect. Although profitability remains unproven, moving toward breakeven can reduce future funding pressure and provides a foundation for a potential turnaround if revenue stabilizes.
Negative Factors
Negative Shareholders’ EquityNegative equity materially weakens financial flexibility and leaves the capital structure vulnerable to further losses or funding needs. It also complicates leverage assessment and means the company must rebuild its equity base through sustained earnings or additional capital before resilience improves.

1st Group Ltd. (VFX) vs. iShares MSCI Australia ETF (EWA)

-75%-50%-25%0%25%50%75%AU:VFX-48.68%EWA+17.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
AUD 3.39M
Dividend Yield
―
Average Volume (3M)
19.78K
Price to Earnings (P/E)
-195.0
Beta (1Y)
0.47
Revenue Growth
-10.07%
EPS Growth
99.60%
Country
Australia
Employees
10
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

1st Group Ltd. Business Overview & Revenue Model

Company Description

Operating in Australia, Visionflex Group Limited and its associated companies specialize in providing cutting-edge healthcare, telehealth, and remote diagnostic services. The company's portfolio features virtual healthcare systems and specialized med...

1st Group Ltd. Financial Statement Overview

Summary

The company is in severe financial distress. Revenue is declining, gross margins are deeply negative, and operating losses are massive. The balance sheet shows technical insolvency with negative equity, and cash flow is deeply negative, indicating an unsustainable cash burn. The overall financial picture is one of a company bordering on non-viability.

Income Statement

8Very Negative

Balance Sheet

1Very Negative

Cash Flow

5Very Negative
Financial statement breakdown
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue4.18M4.14M4.19M6.65M4.47M4.83M
Gross Profit-840.06K-887.14K-2.42M3.94M3.41M4.83M
EBITDA-2.01M-2.06M-3.37M-1.32M-3.56M-6.44M
Net Income-57.80K-57.80K-3.19M-1.83M-3.66M-6.82M
Balance Sheet
Total Assets3.09M3.09M3.39M2.88M4.09M4.27M
Cash, Cash Equivalents and Short-Term Investments1.62M1.62M1.89M1.16M1.44M2.01M
Total Debt577.99K577.99K2.47M13.65M12.11M4.65M
Total Liabilities3.11M3.11M5.22M19.76M18.73M8.16M
Stockholders Equity-14.69K-14.69K-1.82M-8.11M-6.74M-3.89M
Cash Flow
Free Cash Flow-1.27M-1.27M-3.19M-1.38M-3.68M-2.82M
Operating Cash Flow-1.26M-1.26M-3.16M000
Investing Cash Flow-15.56K-15.56K-29.51K276.80K720.13K-21.84K
Financing Cash Flow1.02M1.02M3.92M798.81K2.36M4.59M

1st Group Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price0.04

Price Trends

50DMA0.04Negative
100DMA0.05Negative
200DMA0.06Negative

Market Momentum

MACD-0.00Negative
RSI27.94Positive
STOCH17.65Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:VFX, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.04, and below the 200-day MA of 0.06, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 27.94 is Positive, neither overbought nor oversold. The STOCH value of 17.65 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:VFX.

1st Group Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

AU:VFX against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
AU:ALCAU:ALC63NeutralAUD 155.23M702.942.53%―26.61%41.67%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
AU:ONEAU:ONE51NeutralAUD 117.49M-6.71-203.69%―-1.53%28.29%
AU:ICRAU:ICR45NeutralAUD 12.16M-5.00-416.53%―113.42%29.17%
AU:BMTAU:BMT40UnderperformAUD 20.08M-1.08-58.13%―2.08%-195.31%
AU:PCKAU:PCK37UnderperformAUD 14.44M-1.59-1688.04%―11.45%0.69%
AU:VFXAU:VFX37UnderperformAUD 3.39M-195.00-84.46%―-10.07%99.60%

* Healthcare Sector Average

Performance Comparison

-50%0%50%AU:VFXAU:ONEAU:BMTAU:ALCAU:ICRAU:PCKDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AU:VFX and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
AU:VFX1st Group Ltd.0.04-0.04-48.68%
AU:ONEOneview Healthcare PLC Chess Depository Interests repr 10.14-0.13-48.15%
AU:BMTBeamtree Holdings Ltd0.07-0.13-66.00%
AU:ALCAlcidion Group Limited0.120.014.55%
AU:ICRInteliCare Holdings Limited0.02-0.01-34.62%
AU:PCKPainChek Ltd0.07-0.35-83.57%

1st Group Ltd. Corporate Events

Visionflex reports lapse of 100,000 performance rights

Nov 3, 2026

Visionflex Group Limited, an ASX-listed entity identified by ticker VFX, does not provide information in the release about its industry, products or market focus. The company reported the cessation of 100,000 VFXAR performance rights on 22 October 20...

Visionflex Seeks ASX Quotation for 25,556 Securities

Nov 2, 2026

Visionflex Group Limited submitted an application for ASX quotation of 25,556 ordinary fully paid securities under ticker VFX. The securities have an issue date of November 2, 2026, expanding the company’s quoted securities on the exchange; the relea...

Visionflex trims costs as aged-care churn hits recurring revenue

Oct 30, 2026

Visionflex Group reported unaudited Q1 FY27 revenue of $0.9 million, a 3% rise on the prior year, with operating and administration payments reduced by 12% to $1.8 million, improving net operating cash outflow to $0.9 million. Customer cash receipts...

Visionflex Posts Quarterly Cash Outflow but Maintains Cash Buffer

Oct 30, 2026

Visionflex Group Limited reported customer receipts of A$893,000 for the quarter ended 30 September 2026, reflecting ongoing demand for its telehealth and digital health solutions. Operating expenditure was driven largely by product manufacturing, st...

Visionflex sets November AGM as it builds out virtual healthcare platform

Oct 19, 2026

Visionflex Group Limited, a specialist in virtual healthcare technology, delivers integrated hardware and software systems that connect healthcare teams to deliver real-time, collaborative care across metropolitan and community settings. The company...

Visionflex Group Seeks ASX Quotation for Additional Ordinary Shares

Sep 30, 2026

Visionflex Group Limited has lodged an application with the ASX for quotation of 95,556 ordinary fully paid shares under its existing issuer code VFX. The securities are to be quoted from September 30, 2026, expanding the company’s listed share base...

Visionflex hires related-party consultants to design exemplar mobile clinic

Sep 18, 2026

Visionflex Group has engaged two related-party consultancies, Yotchi Pty Limited and Sixth Street Pty Ltd, to design and cost an exemplar mobile clinic vehicle as part of an investment evaluation for its virtual healthcare offerings. The fixed-fee ag...

Visionflex seeks ASX quotation for new share issue

Sep 18, 2026

Visionflex Group Limited has applied for the quotation of 51,350 ordinary fully paid shares on the Australian Securities Exchange, with the new securities issued on 17 September 2026. The application follows the exercise or conversion of options or o...

Visionflex files Appendix 4G and updates corporate governance statement

Aug 28, 2026

Visionflex Group Limited has lodged its Appendix 4G and updated Corporate Governance Statement for the financial year ended 30 June 2026, in line with ASX listing rule requirements. The governance statement, approved by the board and made available v...

Visionflex Narrows Losses and Builds Recurring Revenue Despite FY26 Sales Dip

Aug 28, 2026

Visionflex Group reported FY26 revenue of $4.2 million, down 10% due to customer deferrals of hardware deliveries into FY27, but significantly improved profitability metrics, including an 86% gross margin and an 84% reduction in statutory loss before...

Visionflex Group Tables 2026 Annual Report for Investors

Aug 28, 2026

Visionflex Group Limited has released its 2026 annual report, which compiles key governance, financial, and operational disclosures for investors. The report includes chair and CEO commentary, detailed directors’ and remuneration reports, primary fin...

Visionflex slashes annual loss but auditor flags going-concern risks

Aug 28, 2026

Visionflex Group Limited reported a 10% decline in revenue to $4.18 million for the year ended 30 June 2026, but drastically reduced its net loss to $54,772 from $3.09 million a year earlier. The company did not declare dividends and its net tangible...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 01, 2026